Subcloning and Transformation of a Portion of the Gene Encoding the ISG-75 N-terminal Domain of Trypanosoma brucei
Keywords:
MedicineAbstract
Objectives: African trypanosomiasis is a parasitic disease caused by Trypanosoma brucei and transmitted by the tsetse fly. Trypanosomes evade the immune system by altering their surface structure, which contains a layer of 107 variant surface glycoprotein (VSG) that partially shield a number of underlying invariant surface glycoproteins (ISGs).1,2 Understanding invariant surface glycoproteins has been the recent focus of study for vaccine development and chemotherapy. Since its discovery, ISG-75 has received little study despite the fact its sequence is unique and not related to any other ISG. The focus of this project was to subclone the portion of the gene encoding the 440 amino acid N-terminal domain of ISG-75. The recombinant domain was purified and used to raise antibodies for use as a reagent to determine the orientation of ISG-75 in live bloodborne trypanosomes. The orientation of this protein is important, both for academic reasons in the attempt to understand its function and practically, as a possible target for parasite control by chemotherapy or immune control via a single chain. This involves the production of a single domain recombinant antibody that would be small enough to pass the VSG barrier and reach its ISG target. Understanding which part of the protein is exposed externally on the cellular surface is critical in selecting the portion of the protein to target. Methods: Polymerase Chain Reaction (PCR) was performed using genomic DNA to obtain the N-terminal domain of ISG-75. The gene fragment encoding the N-terminal domain of ISG-75 and the pET-21a vector were successfully double digested with the restriction enzymes, Nde1 and Not1. The insert and vector were cut from 1% agarose gels and extracted from the gel material. They were then ligated together and transformed into E. coli. Results: The N-terminal domain measured 1354 basepairs after PCR. After incubating the insert and vector with the restriction enzymes the N-terminal domain was visible in the appropriate region. Two smaller band fragments 600 and 754 basepairs in length were also identified. The pET-21a vector was found in the appropriate region and measured 5443 basepairs in length. E. coli colony counts where performed on both the ligation mixture and control LB agar plates. Thirteen colonies were found on the ligation mixture plate.
References
2. Van der Ploeg LHT, Bernards A, Rijswijk FAM, Borst P. Characterization of the DNA duplication- transposition that controls the expression of two genes for variant surface glycoproteins in Trypanosoma brucei. Nucleic Acids Res. 1982:10: 593-609.
3. Kuzoa FA. Current situation of African trypanosomiasis. Acta Tropica. 1993; 10: 153-62.
4. Hursey BS, Slingenbergh J. The tsetse fly and its effects on agriculture in sub-Saharan Africa. World Animal Review, 1995; 3-4: 67-73.
5. Zeibig E.A. Clinical Parasitology: A Practical Approach. Philadelphia, PA: W.B. Saunders Company; 1997.
6. Cross GA. Cellular and genetic aspects of antigenic
variation in trypanosomes. Annu Rev Immunol. 1990; 8: 83-770.
7. Borst P. Transferrin receptor, antigenic variation and the prospect of a trypanosome vaccine. Trends Genet. 1991a; 7: 307-9.
8. Bringaud F, Baltz T. African trypanosome glucose transporter genes: organization and evolution of a multigene family. Mol Cell Biol. 1993;13:1146-54.
9. Ziegelbauer K, Overath P. Identification of invariant surface glycoproteins in the bloodstream stage of Trypanosoma brucei. J Biol Chem. 1992; 267: 10791- 96.
10. Ziegelbauer K, Multhaup G, Overath P. Molecular characterization of two invariant surface glycoproteins specific for the bloodstream stage of Trypanosoma brucei. J Biol Chem. 1992; 267: 10797-803.
11. Jackson DG, Windle H, Voorheis H. The identification, purification, and characterization of two invariant surface glycoproteins located beneath the surface coat barrier of bloodstream forms of Trypanosoma brucei. J Biol Chem. 1993; 268: 8085- 95.
12. Borst P. Molecular genetics of antigenic variation. Immunol Today 1991b; 12: A29-A33.
13. Salmon D, Geuskens M, Hanocq F, Hanocq- Quertier J, et al. A novel heterodimeric transferrin receptor encoded by a pair of VSG expression site- associated genes in T. brucei. Cell 1994; 78: 75-86. 14. Ligtenberg MJL, Bitter W, Kieft R, Steverding D, et al. Reconstitution of a surface transferrin binding complex in insect form Trypanosoma brucei.
EMBO J. 1994; 13: 2565-73.
15. Chaudhri M, Steverding D, Kittelberger D, Overath P. Expression of a glycosylphosphatidylinositol- anchored Trypanosoma brucei transferrin-binding protein complex in insect cells Proc Natl Acad Sci. 1994; 91: 6443-47.
16. Rolin S, Halleux St, Van Sande J, Dumont JE, et al.
Stage-specific adenylate cyclase activity in Trypanosoma brucei. Exp Parasitol.1990; 71: 350-2. 17. Paindavoine P, Rolin S, Van Assel S, Geuskens M, et al. A gene from the variant surface glycoprotein expression site encodes one of several transmembrane adenylate cyclases located on the flagellum of Trypanosoma brucei. Mol Cell Biol. 1992 Mar; 12(3):1218-25.
18. Nolan DP, Jackson DG, Windle HJ, Pays A, et al. Characterization of a novel, stage-specific, invariant surface protein in Trypanosoma brucei containing an internal, serine-rich, repetitive motif. J Biol Chem. 1997 Nov 14; 272(46):29212-21.
19. Ziegelbauer K, Rudenko G, Kieft R, Overath P. Genomic organization of an invariant surface glycoprotein gene family of Trypanosoma brucei. Mol Biochem Parasitol.1995; 69: 53-63.
20. Gleeson, M. Protein Composition. 2001. Available from : URL : http://www.up.univ- mrs.fr/~wabim/d_abim/compo-p.html.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.